F. Caux - Concepedia

Author

F. Caux

Also Known As

Borradori, Luca, Christelle Le Roux-Villet, F Caux, F. CAUX, F. Caux, FRÉDÉRIC CAUX, Frederic CAUX, Frederic Caux, Fréderic Caux, Frédéric A. Caux

304

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

Université Sorbonne Paris Nord Inserm Assistance Publique – Hôpitaux de Paris Université Paris Cité Université de Rouen Normandie

About

F. Caux is an author at Université Sorbonne Paris Nord specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	3K
2	Natural Sciences	2	2	499
3	Public Health	1	1	20
4	Allergy	1	1	55
5	Biochemistry	1	1	460

F. Caux

Publications

Citations

H-Index

Page 1

	Year	Citations
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni, The Lancet Ritux 3PharmacologyPharmacotherapyMedicineFirst-line Rituximab	2017	586
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus P. Joly, Hugo Mouquet, Jean‐Claude Roujeau, New England Journal of Medicine	2007	460
Mutations in CGI-58, the Gene Encoding a New Protein of the Esterase/Lipase/Thioesterase Subfamily, in Chanarin-Dorfman Syndrome Caroline Lefèvre, Florence Jobard, F. Caux, The American Journal of Human Genetics Mendelian DisorderBiochemistryGenetic DisorderNatural SciencesGenetics	2001	460
High cumulative risks of cancer in patients with <i>PTEN</i> hamartoma tumour syndrome Virginie Bubien, Françoise Bonnet, Véronique Brouste, Journal of Medical Genetics	2013	358
Diagnosis and management of pemphigus: Recommendations of an international panel of experts Dédée F. Murrell, S.M. Peña, P. Joly, Journal of the American Academy of Dermatology MedicineDermatologyPathologyInternational Panel	2018	356
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) P. Joly, Barbara Horváth, Soner Uzun, Journal of the European Academy of Dermatology and Venereology	2020	319
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response Natacha Colliou, D Picard, Frédérique Caillot, Science Translational Medicine	2013	238
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study P. Joly, Jean‐Claude Roujeau, Jacques Bénichou, Journal of Investigative Dermatology Bullous PemphigoidClinical DermatologyDermatologyTopical CorticosteroidsDermatopathology	2009	238
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>) Luca Borradori, Nina van Beek, Claudio Feliciani, Journal of the European Academy of Dermatology and Venereology	2022	225
A Highly Sensitive Enzyme-Linked Immunosorbent Assay for the Detection of Circulating Anti-BP180 Autoantibodies in Patients with Bullous Pemphigoid Detlef Zillikens, José M. Mascaró, Pamela A. Rose, Journal of Investigative Dermatology Autoimmune DiseaseAutoantibody ProductionMedicineImmunologySerologic Testing	1997	224

Page 1